Unlike other patient samples, leukemias containing the E2A-PBX1 fusion protein consistently exhibit BCL-2 expression levels similar to those of normal pre-B cells and lower than those of MLL-r and other leukemias [18] (Fig. 6A). This evidence concerns the gene BCL2 and leukemia.